Novo Holdings A/S
10% owner at Edgewise Therapeutics; 10% owner at Hemab Therapeutics Holdings; 10% owner at Avalyn Pharma.
- Rank
- 237th of 809
- Companies held
- 9
- Largest holding
- EWTX, 39.2% of total
- Latest SEC filing
- May 4, 2026
What the $638M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Edgewise Therapeutics EWTX COMMON STOCK | Directly | 6,071,703 | $41.17 | $250M | 39.2% | Form 4, Sep 14, 2022 |
| Hemab Therapeutics Holdings COAG Common Stock | Directly | 4,180,550 | $39.86 | $167M | 26.1% | Form 4, May 4, 2026 |
| Avalyn Pharma AVLN Voting Common Stock | Directly | 3,883,289 | $28.70 | $111M | 17.5% | Form 4, May 1, 2026 |
| Disc Medicine IRON Common Stock | Directly | 1,090,772 | $76.11 | $83.0M | 13.0% | Form 4, Jun 28, 2023 |
| MapLight Therapeutics MPLT Voting Common Stock | Directly | 3,686,622 | $6.42 | $23.7M | 3.7% | Form 4, Oct 28, 2025 |
| Metagenomi Therapeutics MGX COMMON STOCK | Directly | 1,739,175 | $0.61 | $1.1M | 0.2% | Form 4, Feb 13, 2024 |
| Bolt Biotherapeutics BOLT COMMON STOCK | Directly | 185,200 split-adjusted | $5.06 | $937K | 0.1% | Form 4, Jul 13, 2022 |
| OnKure Therapeutics OKUR Common Stock | Directly | 333,034 split-adjusted | $2.76 | $919K | 0.1% | Form 4, Jun 23, 2023 |
| Spruce Biosciences SPRB COMMON STOCK | Directly | 453 split-adjusted | $40.49 | $18K | 0.0% | Form 4, Mar 21, 2024 |
Share counts are the amounts Novo Holdings A/S reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 234 | BCPE Derby (DE) SPV, LP 10% owner, Waystar Holding | $648M |
| 235 | Gilead Sciences, Inc. 10% owner, Arcus Biosciences | $641M |
| 236 | Corsair Group (Cayman), LP 10% owner, Corsair Gaming | $639M |
| 237 | Novo Holdings A/S 10% owner, Edgewise Therapeutics | $638M |
| 238 | WindAcre Partnership Master Fund, LP 10% owner, Perimeter Group | $633M |
| 239 | Public Investment Fund Director, Lucid Group | $624M |
| 240 | Apollo Management IX, L.P. 10% owner, TD SYNNEX | $622M |
Other Edgewise Therapeutics insiders
All EWTX insiders- Kevin Koch$13.9MPresident and CEO. #6826 overall
- Jonathan D. Root$643KDirector. #7686 overall
Questions
How much stock does Novo Holdings A/S own?
Novo Holdings A/S holds $637,688,044 in listed stock based on SEC filings and current prices, mostly Edgewise Therapeutics (EWTX). That ranks 237th on the Stock Rich List.
Is this Novo Holdings A/S's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Novo Holdings A/S last buy or sell stock?
The most recent open-market trade on file is a purchase of 555,555 AVLN shares on May 1, 2026 at $18.00.